UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1955-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.ovc.umsmed.edu
Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis
Phase 3
Completed
- Conditions
- Gastroparesis
- Interventions
- Device: Gastric Electrical Stimulator, Enterra, Medtronics, Inc.
- First Posted Date
- 2007-02-08
- Last Posted Date
- 2012-12-03
- Lead Sponsor
- University of Mississippi Medical Center
- Target Recruit Count
- 58
- Registration Number
- NCT00432835
- Locations
- 🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
Split-Thickness Skin Graft Donor Site Wound Healing Study
Withdrawn
- Conditions
- Split-thickness Skin Graft Donor Sites
- First Posted Date
- 2006-10-25
- Last Posted Date
- 2018-02-22
- Lead Sponsor
- University of Mississippi Medical Center
- Registration Number
- NCT00392301
- Locations
- 🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
Impact of Screening Patients With HIV for Kidney Disease
Withdrawn
- Conditions
- ProteinuriaHIV InfectionsRenal Insufficiency, Chronic
- First Posted Date
- 2006-10-25
- Last Posted Date
- 2018-05-30
- Lead Sponsor
- University of Mississippi Medical Center
- Registration Number
- NCT00392132
- Locations
- 🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
Does An Abnormal PFA 100 Predict Bleeding After Renal Biopsy?
Phase 4
Terminated
- Conditions
- Kidney Failure, ChronicHemorrhageKidney Failure, AcuteBlood Platelet Disorders
- Interventions
- Device: measuring Platelet Function Analyser-100 (PFA-100) platelet function before kidney biopsy
- First Posted Date
- 2006-06-06
- Last Posted Date
- 2013-08-01
- Lead Sponsor
- University of Mississippi Medical Center
- Target Recruit Count
- 58
- Registration Number
- NCT00334204
- Locations
- 🇺🇸
University of Mississipppi Medical Center, Adult Hospital, Jackson, Mississippi, United States
Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy
- First Posted Date
- 2006-05-24
- Last Posted Date
- 2008-06-04
- Lead Sponsor
- University of Mississippi Medical Center
- Target Recruit Count
- 14
- Registration Number
- NCT00329381
- Locations
- 🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis
Not Applicable
Completed
- Conditions
- Seasonal Allergic Rhinitis
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2007-01-26
- Lead Sponsor
- University of Mississippi Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT00227058
- Locations
- 🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
Soluble CD23 Expression in Asthma Patients Treated With OMA
Not Applicable
Terminated
- Conditions
- Asthma
- First Posted Date
- 2005-09-26
- Last Posted Date
- 2008-12-01
- Lead Sponsor
- University of Mississippi Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT00226200
- Locations
- 🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
Dietary Intervention Study for Hypertension (DISH)
Phase 3
Completed
- Conditions
- Vascular DiseasesCardiovascular DiseasesHeart DiseasesHypertension
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2015-04-15
- Lead Sponsor
- University of Mississippi Medical Center
- Registration Number
- NCT00000497
© Copyright 2025. All Rights Reserved by MedPath